Age-related inflammatory changes in the spine as demonstrated by 18F-FDG-PET: Observation and insight into degenerative spinal changes

Hellenic Journal of Nuclear Medicine

Volumn 15, Issue 3, 2012, Pages

  Aliyev, Anar ^a   Saboury, Babak ^a   Kwee, Thomas C ^b   Torigian, Drew A ^a   Basu, Sandip ^a,c   Christensen, Henrik Wulff ^d   Alavis, Abass ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c TATA MEMORIAL HOSPITAL   (India)

^d Nordic Institute for Chiropractics and Clinical Biomechanics   (Denmark)

Author keywords

18F FDG PET; Aging; Disc; Inflammation; Spine; Spinous process

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; AGING; ARTICLE; CLINICAL ARTICLE; CORRELATION COEFFICIENT; DRUG UPTAKE; FEMALE; HUMAN; INFLAMMATION; INTERVERTEBRAL DISK DEGENERATION; MALE; POSITRON EMISSION TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; AGING; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INTERVERTEBRAL DISC DEGENERATION; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPONDYLITIS; YOUNG ADULT;

EID: 84871856420     PISSN: 17905427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Benoist M. Natural history of the aging spine. Eur Spine J 2003; 12 Suppl 2: S86-9. (Pubitemid 37409925)
2. Andersson GB. What are the age-related changes in the spine? Baillieres Clin Rheumatol 1998; 12: 161-73. (Pubitemid 28274307)
3. Podichetty VK. The aging spine: the role of inflammatory mediators in intervertebral disc degeneration. Cell Mol Biol 2007 (Noisy-le-grand); 53: 4-18.
4. Baur-Melnyk A, Triantafyllou M, Birkenmaier C, Reiser M. Degenerative diseases of the spine: Rare and often unrecognized causes of pain syndromes. Radiologe 2006; 46: 454-67. (Pubitemid 43926888)
5. Basu S, Chryssikos T, Moghadam-Kia S et al. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med 2009; 39: 36-51.
6. Basu S, Zhuang H, Torigian DA et al. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med 2009; 39: 124-45.
7. Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology 2004; 231: 305-32. (Pubitemid 38552885)
8. Yamada S, Kubota K, Kubota R et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995; 36: 1301-6.
9. 18F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 2002; 43: 658-63.
10. 18F-FDG shoulder uptake on PET is associated with clinical findings of osteoarthritis. Am J Roentgenol 2005; 185: 797-803.
11. 18F-FDG in osteoarthritic knee. Osteoarthritis Cartilage 2007; 15: 673-81.
12. Schmitz A, Risse JH, Grónwald F et al. Fluorine-18 fluorodeoxy-glucose positron emission tomography findings in spondylodiscitis: preliminary results. Eur Spine J 2001; 10: 534-9. (Pubitemid 34168541)
13. 18F-FDG-PET/CT findings in patients affected by spondylodiscitis. Hell J Nucl Med 2010; 13: 166-8.
14. 18F-FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 2008; 35: 562-9.